A detailed history of Pictet Asset Management Holding Sa transactions in Merus N.V. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,012,448 shares of MRUS stock, worth $46.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,012,448
Previous 844,474 19.89%
Holding current value
$46.4 Million
Previous $50 Million 1.23%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$47.19 - $58.84 $7.93 Million - $9.88 Million
167,974 Added 19.89%
1,012,448 $50.6 Million
Q2 2024

Aug 13, 2024

BUY
$39.81 - $60.2 $8.55 Million - $12.9 Million
214,799 Added 34.11%
844,474 $50 Million
Q1 2024

May 14, 2024

SELL
$28.03 - $51.82 $16.9 Million - $31.3 Million
-603,133 Reduced 48.92%
629,675 $28.4 Million
Q4 2023

Feb 13, 2024

BUY
$20.06 - $28.66 $24.7 Million - $35.3 Million
1,232,808 New
1,232,808 $33.9 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.1B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.